Identification of hyaluronic acid binding sites in the extracellular domain of CD44
- PMID: 8314845
- PMCID: PMC2119597
- DOI: 10.1083/jcb.122.1.257
Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Abstract
CD44 is a polymorphic glycoprotein expressed on the surface of many tissues and cell lines which has been implicated in a number of cellular functions including lymphocyte homing to mucosal lymphoid tissue (Peyers patches), leukocyte activation, lymphopoiesis, and tumor metastasis. The predominant isoform found on human leukocytes, CD44H, is a receptor for hyaluronic acid. Because of the prominent role CD44 plays in diverse biological processes, we set out to identify the hyaluronic acid binding site(s) in the extracellular domain of CD44H. Using truncation and site-directed mutagenesis we identified two regions containing clusters of conserved basic residues which are important in hyaluronic acid binding. One of these regions is situated near the NH2 terminus and is homologous to other hyaluronic acid binding proteins including cartilage link protein. The other more membrane proximal region lies outside the link protein homologous domain. Mutagenesis of basic residues within these regions established their role as determinants in hyaluronic acid binding. Mutation of Arg 41, a position where a basic residue is conserved in all hyaluronic acid binding proteins, completely abolished binding suggesting that this residue plays a critical role in hyaluronic acid binding.
Similar articles
-
Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.J Cell Biol. 1994 Aug;126(4):1099-109. doi: 10.1083/jcb.126.4.1099. J Cell Biol. 1994. PMID: 7519619 Free PMC article.
-
Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.J Immunol. 1993 Dec 1;151(11):6490-9. J Immunol. 1993. PMID: 7504022
-
A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.J Exp Med. 1996 May 1;183(5):1987-94. doi: 10.1084/jem.183.5.1987. J Exp Med. 1996. PMID: 8642309 Free PMC article.
-
[CD44, the hyaluronic acid cell receptor. Its role in neoplastic invasion and metastatic dissemination].Bull Cancer. 1993 Oct;80(10):833-44. Bull Cancer. 1993. PMID: 7515731 Review. French.
-
CD44: the hyaluronan receptor.J Cell Sci. 1992 Oct;103 ( Pt 2):293-8. doi: 10.1242/jcs.103.2.293. J Cell Sci. 1992. PMID: 1282514 Review. No abstract available.
Cited by
-
Polysaccharide nanosystems for future progress in cardiovascular pathologies.Theranostics. 2014 Mar 11;4(6):579-91. doi: 10.7150/thno.7688. eCollection 2014. Theranostics. 2014. PMID: 24723980 Free PMC article. Review.
-
Extending the Martini 3 Coarse-Grained Force Field to Hyaluronic Acid.J Phys Chem B. 2025 Mar 6;129(9):2408-2425. doi: 10.1021/acs.jpcb.4c08043. Epub 2025 Feb 23. J Phys Chem B. 2025. PMID: 39988846 Free PMC article.
-
Recent advances in bladder cancer stem cells (BCSCs): A descriptive review of emerging therapeutic targets.iScience. 2025 May 22;28(7):112720. doi: 10.1016/j.isci.2025.112720. eCollection 2025 Jul 18. iScience. 2025. PMID: 40635786 Free PMC article. Review.
-
CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.Front Immunol. 2015 May 26;6:235. doi: 10.3389/fimmu.2015.00235. eCollection 2015. Front Immunol. 2015. PMID: 26074915 Free PMC article. Review.
-
Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells.ACS Omega. 2017 Nov 30;2(11):7702-7713. doi: 10.1021/acsomega.7b01168. Epub 2017 Nov 9. ACS Omega. 2017. PMID: 30023561 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous